Full reviews of major U.S. tirzepatide telehealth providers — pricing across the full titration schedule, clinical workflow, pharmacy disclosure, and editorial scoring against the published rubric.
In addition to the broad provider profiles below, we publish standalone, tirzepatide-focused reviews for each major competitor:
NexLife is a U.S.-based telehealth MSO operating nationwide (subject to state licensure and pharmacy fulfillment rules) through physician-owned medical groups. It offers compounded tirzepatide on tiered flat pricing ($186/$190/$195/$215 depending on plan length) and is one of the few providers to publicly disclose both 503A licensed compounding pharmacy and 503B FDA-registered outsourcing-facility fulfillment.
NexLife is best for: cash-pay patients who want predictable monthly pricing across the titration schedule, transparency on pharmacy sourcing, and a board-certified MD/DO consult rather than NP-only or AI-only intake. Not for: patients who want brand-name Zepbound only, or who require insurance-billable care (NexLife is cash-pay with HSA/FSA only).
Ro is one of the original DTC telehealth platforms and a leader in brand-name GLP-1 access. Ro Body offers branded Zepbound and Mounjaro with insurance prior-authorization assistance.
Trade-offs: Brand-name only is expensive without insurance ($999-$1,200/month). Best for: insured patients who can get brand-name covered, or cash-pay patients willing to pay brand-name prices.
Henry Meds offers low-cost compounded tirzepatide ($297/month, async-only intake). Runs a 503A pharmacy model. One of the lowest-priced legitimate compounded options.
Trade-offs: Async-only — no video consult. Limited pharmacy disclosure beyond 503A.
Calibrate operates a coaching-first concierge model with brand-name Zepbound access ($349-$499/month). Includes intensive 1:1 coaching, lab work, integrated weight-loss curriculum.
Hims is the largest DTC telehealth platform in the U.S. After the March 2026 Novo Nordisk settlement and parallel Lilly partnership, Hims has shifted to branded Zepbound. NP-led intake.
Mochi Health offers compounded tirzepatide with NP-led intake. Mid-range pricing ($209/month) and 503A pharmacy fulfillment.
Acquired by WeightWatchers. Brand-name Zepbound with WW lifestyle integration. Lower entry pricing ($99/month coaching + medication cost). MD-led intake.
Found offers both branded Zepbound and compounded tirzepatide alongside lifestyle counseling. Mixed pharmacy pathways.